No-Cost, No-Obligation Ethicon Physiomesh Attorney Case Review

Ethicon Physiomesh Attorney
Ethicon Physiomesh Lawsuit News

Ethicon Physiomesh Trial Scheduled To Proceed

Physiomesh Composite hernia repair patients eagerly await the first bellwether trial

Monday, May 28, 2018 - Close to 1 million people per year in the United States have hernia repair surgery, the most common being inguinal hernias, (groin), and ventral hernias (abdominal). The average hernia patient is a 40-year old male. The most common sign of a hernia is a noticeable bulge and the most common symptom is the pain. Most hernia bulges will flatten out when a person lays down or presses on it. Hernias require immediate and sometimes emergency medical attention.

Ethicon Inc., a medical devices unit of Johnson & Johnson, first introduced the Physiomesh hernia repair product to the world market in 2010. Since then the company sold more than 300,000 units of the mesh screen-like device to doctors who in turn used them in laparoscopic surgery to repair abdominal hernias. In laparoscopic surgery, a small incision is made, usually, less than a centimeter in diameter and a micro camera and the Physiomesh hernia repair screen inserted. The mesh is placed over the spot of the weakness in the stomach or abdominal wall. The mesh is made from Polypropylene fibers that are intended to irritate the tissue to cause the body to respond with scar tissue and hold the device in place. Unfortunately, it has been determined by surgeons that have had to remove the device that the material used buckles and disintegrates rather than stay intact and support a hernia. When the device buckles or breaks it comes loose and can migrate within the abdominal cavity and usually ends up adhering to the intestines where it causes blockages and perforation.

For a time, Physiomesh was considered a breakthrough medical device until European database studies found an abnormally high percentage of Physiomesh patients, up to 20%, had reported having an adverse event that required revision surgery. As a result of these complaints, Ethicon voluntarily issued a "worldwide market withdrawal" of the product and took Physiomesh off the market without admitting whether or not there was a defect or if so, what that defect might be. Ethicon had rushed the product to market under the FDA's 510(k) fast-track program, side-stepping human testing by showing that the medical device is substantially similar to others that have already been tested and are on the market. Ethicon was already dealing with thousands of lawsuits from another mesh-related debacle, the transvaginal hernia mesh that had to be recalled due to causing incontinence in women.

Physiomesh patients have reported that the product has caused them extreme pain, infections, intestinal blockage, and the need to have an original hernia repaired for the second time. Although rare in traditional hernia repair surgery, Physiomesh failure can cause an original hernia to rupture and require emergency surgery.

Thousands of people have had to have revision surgery to replace the defective Physiomesh Composite hernia repair mesh and are hiring Physiomesh lawyers to sue Ethicon for negligence in rushing a defective product to market. Cases against Ethicon have been consolidated into Federal multi-district litigation for the purpose of streamlining the discovery and pretrial process. The first, bellwether Ethicon Physiomesh trial is scheduled for September 2018.

More Recent Ethicon Physiomesh Lawsuit News:

Lawyers for Ethicon Physiomesh Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.